Elanco Animal Health Debt to Equity Ratio 2016-2026 | ELAN
Current and historical debt to equity ratio values for Elanco Animal Health (ELAN) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Elanco Animal Health debt/equity for the three months ending June 30, 2026 was 0.58.
| Elanco Animal Health Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2026-06-30 | $6.97B | $6.59B | 1.06 |
| 2026-03-31 | $6.72B | $6.50B | 1.03 |
| 2025-12-31 | $6.81B | $6.55B | 1.04 |
| 2025-09-30 | $6.80B | $6.75B | 1.01 |
| 2025-06-30 | $6.97B | $6.78B | 1.03 |
| 2025-03-31 | $6.59B | $6.35B | 1.04 |
| 2024-12-31 | $6.52B | $6.10B | 1.07 |
| 2024-09-30 | $6.76B | $6.52B | 1.04 |
| 2024-06-30 | $7.82B | $5.94B | 1.32 |
| 2024-03-31 | $7.96B | $6.06B | 1.32 |
| 2023-12-31 | $8.14B | $6.22B | 1.31 |
| 2023-09-30 | $8.21B | $6.13B | 1.34 |
| 2023-06-30 | $8.38B | $7.42B | 1.13 |
| 2023-03-31 | $8.29B | $7.48B | 1.11 |
| 2022-12-31 | $8.20B | $7.29B | 1.13 |
| 2022-09-30 | $8.20B | $6.75B | 1.22 |
| 2022-06-30 | $8.46B | $7.14B | 1.19 |
| 2022-03-31 | $8.64B | $7.61B | 1.14 |
| 2021-12-31 | $8.97B | $7.51B | 1.20 |
| 2021-09-30 | $8.88B | $7.68B | 1.16 |
| 2021-06-30 | $8.85B | $7.98B | 1.11 |
| 2021-03-31 | $8.98B | $8.01B | 1.12 |
| 2020-12-31 | $9.22B | $8.48B | 1.09 |
| 2020-09-30 | $8.89B | $8.34B | 1.07 |
| 2020-06-30 | $3.22B | $6.65B | 0.49 |
| 2020-03-31 | $3.07B | $6.66B | 0.46 |
| 2019-12-31 | $3.44B | $5.55B | 0.62 |
| 2019-09-30 | $3.34B | $5.49B | 0.61 |
| 2019-06-30 | $3.59B | $5.27B | 0.68 |
| 2019-03-31 | $3.55B | $5.20B | 0.68 |
| 2018-12-31 | $3.76B | $5.20B | 0.72 |
| 2018-09-30 | $4.07B | $5.14B | 0.79 |
| 2018-06-30 | $0.00B | $0.00B | 0.00 |
| 2018-03-31 | $0.00B | $0.00B | 0.00 |
| 2017-12-31 | $0.00B | 0.00 | |
| 2017-09-30 | $0.00B | $0.00B | 0.00 |
| 2016-12-31 | $1.07B | $7.03B | 0.15 |
| 2015-12-31 | $0.00B | $0.00B | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $11.491B | $4.715B |
| Elanco Animal Health Incorporated operates as an animal health care company. It develops, manufactures and markets products for companion and food animals. Elanco Animal Health Incorporated is based in Greenfield, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $29.581B | 13.26 |
| Quest Diagnostics (DGX) | United States | $27.271B | 23.22 |
| DaVita (DVA) | United States | $12.179B | 14.91 |
| Encompass Health (EHC) | United States | $12.036B | 20.89 |
| Chemed (CHE) | United States | $6.620B | 23.60 |
| RadNet (RDNT) | United States | $6.069B | 175.27 |
| LifeStance Health (LFST) | United States | $4.991B | 100.46 |
| Option Care Health (OPCH) | United States | $3.523B | 14.89 |
| Aveanna Healthcare Holdings (AVAH) | United States | $3.123B | 21.68 |
| Addus HomeCare (ADUS) | United States | $2.164B | 19.57 |
| Astrana Health (ASTH) | United States | $2.138B | 22.69 |
| Pennant (PNTG) | United States | $1.396B | 36.34 |
| U.S Physical Therapy (USPH) | United States | $1.220B | 32.19 |
| Daxor (DXR) | United States | $0.065B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.024B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |